The time-of-day variation in vascular smooth muscle contractility depends on a nitric oxide signalling pathway

Journal of Molecular and Cellular Cardiology

Volumn 66, Issue , 2014, Pages 133-140

  Denniff, M ^a   Turrell, Helen E ^a   Vanezis, Andrew ^a   Rodrigo, Glenn C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Alpha1 adrenergic receptor; Circadian clock; Mesenteric arteries; Nitric oxide synthase; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PER2 PROTEIN; PHENYLEPHRINE; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION; TIME; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

ANIMALIA; RATTUS;

ALPHA1-ADRENERGIC RECEPTOR; CIRCADIAN CLOCK; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; CIRCADIAN CLOCKS; GENE EXPRESSION REGULATION; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84890004268     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.11.009     Document Type: Article

References (43)

1. Degaute J.P., van de Borne P., Linkowski P., Van Cauter E. Quantitative analysis of the 24-hour blood pressure and heart rate patterns in young men. Hypertension 1991, 18:199-210.
2. Sindrup J.H., Kastrup J., Christensen H., Jorgensen B. Nocturnal variations in peripheral blood flow, systemic blood pressure, and heart rate in humans. Am J Physiol 1991, 261:H982-H988.
3. Engel B.T., Talan M.I. Diurnal patterns of hemodynamic performance in nonhuman primates. Am J Physiol 1987, 253:R779-R785.
4. Veerman D.P., Imholz B.P., Wieling W., Wesseling K.H., van Montfrans G.A. Circadian profile of systemic hemodynamics. Hypertension 1995, 26:55-59.
5. Smith T.L., Coleman T.G., Stanek K.A., Murphy W.R. Hemodynamic monitoring for 24h in unanesthetized rats. Am J Physiol 1987, 253:H1335-H1341.
6. Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease-from mice and man. Pharmacol Ther 2006, 111:629-651.
7. Verdecchia P., Schillaci G., Porcellati C. Dippers versus non-dippers. J Hypertens Suppl 1991, 9:S42-S44.
8. Casiglia E., Palatini P., Ginocchio G., Biasin R., Pavan L., Pessina A.C. Leg versus forearm flow: 24h monitoring in 14 normotensive subjects and in 14 age-matched hypertensive patients confined to bed. Am J Hypertens 1998, 11:190-195.
9. Witte K., Schnecko A., Buijs R.M., van der Vliet J., Scalbert E., Delagrange P., et al. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol Int 1998, 15:135-145.
10. Imai Y., Abe K., Munakata M., Sakuma H., Hashimoto J., Imai K., et al. Circadian blood pressure variations under different pathophysiological conditions. J Hypertens Suppl 1990, 8:S125-S132.
11. Keskil Z., Gorgun C.Z., Hodoglugil U., Zengil H. Twenty-four-hour variations in the sensitivity of rat aorta to vasoactive agents. Chronobiol Int 1996, 13:465-475.
12. Witte K., Hasenberg T., Rueff T., Hauptfleisch S., Schilling L., Lemmer B. Day-night variation in the in vitro contractility of aorta and mesenteric and renal arteries in transgenic hypertensive rats. Chronobiol Int 2001, 18:665-681.
13. Shaw J.A., Chin-Dusting J.P., Kingwell B.A., Dart A.M. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 2001, 103:806-812.
14. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 1998, 124:1131-1140.
15. Archer S.L., Huang J.M., Hampl V., Nelson D.P., Shultz P.J., Weir E.K. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 1994, 91:7583-7587.
16. Francis S.H., Busch J.L., Corbin J.D., Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010, 62:525-563.
17. Witte K., Schnecko A., Zuther P., Lemmer B. Contribution of the nitric oxide-guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats. Cardiovasc Res 1995, 30:682-688.
18. Zhdanova I.V., Simmons M., Marcus J.N., Busza A.C., Leclair O.U., Taylor J.A. Nocturnal increase in plasma cGMP levels in humans. J Biol Rhythms 1999, 14:307-313.
19. O'Sullivan S.E., Kendall D.A., Randall M.D. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 2006, 317:428-438.
20. Collins H.E., Rodrigo G.C. Inotropic response of cardiac ventricular myocytes to beta-adrenergic stimulation with isoproterenol exhibits diurnal variation: involvement of nitric oxide. Circ Res 2010, 106:1244-1252.
21. Su W., Xie Z., Guo Z., Duncan M.J., Lutshumba J., Gong M.C. Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol 2012, 302:H621-H633.
22. Carrier G.O., Fuchs L.C., Winecoff A.P., Giulumian A.D., White R.E. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol 1997, 273:H76-H84.
23. anaTunctan B., Weigl Y., Dotan A., Peleg L., Zengil H., Ashkenazi I., et al. Circadian variation of nitric oxide synthase activity in mouse tissue. Chronobiol Int 2002, 19:393-404.
24. Naito Y., Tsujino T., Kawasaki D., Okumura T., Morimoto S., Masai M., et al. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 2003, 21:1107-1115.
25. de Groot A.A., Mathy M.J., van Zwieten P.A., Peters S.L. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta. J Cardiovasc Pharmacol 2003, 42:232-236.
26. Dessy C., Saliez J., Ghisdal P., Daneau G., Lobysheva I.I., Frerart F., et al. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation 2005, 112:1198-1205.
27. Dessy C., Moniotte S., Ghisdal P., Havaux X., Noirhomme P., Balligand J.L. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 2004, 110:948-954.
28. Zhou L., Zhang P., Cheng Z., Hao W., Wang R., Fang Q., et al. Altered circadian rhythm of cardiac beta3-adrenoceptor activity following myocardial infarction in the rat. Basic Res Cardiol 2011, 106:37-50.
29. Briones A.M., Daly C.J., Jimenez-Altayo F., Martinez-Revelles S., Gonzalez J.M., McGrath J.C., et al. Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries. Br J Pharmacol 2005, 146:679-691.
30. Kamm K.E., Stull J.T. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001, 276:4527-4530.
31. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003, 83:1325-1358.
32. Hofmann F. The biology of cyclic GMP-dependent protein kinases. J Biol Chem 2005, 280:1-4.
33. Surks H.K. cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms. Circ Res 2007, 101:1078-1080.
34. Raeymaekers L., Hofmann F., Casteels R. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 1988, 252:269-273.
35. Schlossmann J., Ammendola A., Ashman K., Zong X., Huber A., Neubauer G., et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000, 404:197-201.
36. Murthy K.S., Zhou H., Grider J.R., Makhlouf G.M. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver Physiol 2003, 284:G1006-G1016.
37. Chang H.Y. Role of nitric oxide in vasodilator response induced by salbutamol in rat diaphragmatic microcirculation. Am J Physiol 1997, 272:H2173-H2179.
38. Trochu J.N., Leblais V., Rautureau Y., Beverelli F., Le Marec H., Berdeaux A., et al. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 1999, 128:69-76.
39. Rozec B., Gauthier C. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 2006, 111:652-673.
40. Lemmer B., Arraj M. Effect of NO synthase inhibition on cardiovascular circadian rhythms in wild-type and eNOS-knock-out mice. Chronobiol Int 2008, 25:501-510.
41. Arraj M., Lemmer B. Endothelial nitric oxide is not involved in circadian rhythm generation of blood pressure: experiments in wild-type C57 and eNOS knock-out mice under light-dark and free-run conditions. Chronobiol Int 2007, 24:1231-1240.
42. Kashiwagi S., Kajimura M., Yoshimura Y., Suematsu M. Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography. Circ Res 2002, 91:e55-e64.
43. Durgan D.J., Young M.E. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 2010, 106:647-658.